Comparing Drug Detection in Oral Fluid and Blood: Data From a National Sample of Nighttime Drivers

Traffic Injury Prevention

Volumn 15, Issue 2, 2014, Pages 111-118

  Kelley Baker, T ^a   Moore, C ^b   Lacey, J H ^a   Yao, J ^a  

^a PACIFIC INSTITUTE FOR RESEARCH AND EVALUATION   (United States)

^b Immunalysis Corporation   (United States)

Author keywords

blood; drug testing; National Roadside Survey; oral fluid

Indexed keywords

EID: 84891088958     PISSN: 15389588     EISSN: 1538957X     Source Type: Journal    
DOI: 10.1080/15389588.2013.796042     Document Type: Article

References (34)

1. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 4th ed., Arlington, VA: American Psychiatric Association.
2. Barnes, A J, Scheidweiler, K B, Kolbrich-Spargo, E A, Gorelick, D A, Goodwin, R S and Huestis, M A. 2011. MDMA and metabolite disposition in expectorated oral fluid after controlled oral MDMA administration. Ther Drug Monit, 33: 602 - 608.
3. Brogan, W C, Kemp, P M, Bost, R O, Glamann, D B, Lange, R A and Hillis, LD. 1992. Collection and handling of clinical blood samples to assure the accurate measurement of cocaine concentration. J Anal Toxicol., 16: 152 - 154.
4. Brookoff, D, Cook, C S, Williams, C and Mann, C S. 1994. Testing reckless drivers for cocaine and marijuana. N Engl J Med., 331: 518 - 522.
5. Bush, DM. 2008. The US mandatory guidelines for federal workplace drug testing programs: current status and future considerations. Forensic Sci Int., 174: 111 - 119.
6. Coulter, C, Miller, E, Krompton, K and Moore, C. 2008. Tetrahydrocannabinol and two of its metabolites in whole blood using liquid chromatography-tandem mass spectrometry. J Anal Toxicol., 32: 653 - 658.
7. Executive Office of the President of the United States. National Drug Control Strategy, Washington, DC: Executive Office of the President of the United States. Available at: http://www.whitehouse.gov/sites/default/files/ondcp/ndcs2011.pdf 2011
8. Gjerde, H, Mordal, J, Christophersen, A S, Bramness, J G and Mørland, J. 2010. Comparison of drug concentrations in blood and oral fluid collected with the Intercept sampling device. J Anal Toxicol, 34: 204 - 209.
9. Gjerde, H and Verstraete, AG. 2011. Estimating equivalent cutoff thresholds for drugs in blood and oral fluid using prevalence regression: a study of tetrahydrocannabinol and amphetamine. Forensic Sci Int., 212: 26 - 30.
10. Hamilton, JG. 1995. Needle phobia: a neglected diagnosis. J Fam Pract., 41: 169 - 175.
11. Huestis, M A and Cone, EJ. 2007. Methamphetamine disposition in oral fluid, plasma, and urine. Ann N Y Acad Sci., 1098: 104 - 121.
12. Huestis, M A, Verstraete, A, Kwong, T C, Morland, J, Vincent, M J and de la Torre, R. 2011. Oral fluid testing: promises and pitfalls. Clin Chem., 57: 805 - 810.
13. Jones, AW. 2005. Driving under the influence of drugs in Sweden with zero concentration limits in blood for controlled substances. Traffic Inj Prev., 6: 317 - 322.
14. Jones, A W, Holmgren, A and Kugelberg, FC. 2007. Concentrations of scheduled prescription drugs in blood of impaired drivers: considerations for interpreting the results. Ther Drug Monit., 29: 248 - 260.
15. Lacey, J H, Kelley-Baker, T, Furr-Holden, C DM, Brainard, K and Moore, C. 2007. Pilot Test of New Roadside Survey Methodology for Impaired Driving, Washington, DC: National Highway Traffic Safety Administration. DOT HS 810 704. Available at: http://www.nhtsa.gov/DOT/NHTSA/Traffic%20Injury%20Control/Articles/Associated%20Files/PilotTest_NRSM.pdf
16. Lacey, J H, Kelley-Baker, T Furr-Holden, D. 2007. National Roadside Survey of Alcohol and Drug Use by Drivers: Methodology, Washington, DC: US Department of Transportation, National Highway Traffic Safety Administration. 2009. Report No. DOT HS 811 237. Available at: http://www.nhtsa.gov/Driving+Safety/Research+&+Evaluation/2007+National+Roadside+Survey+of+Alcohol+and+Drug+Use+by+Drivers
17. Lacey, J H, Kelley-Baker, T Voas, R B. 2011. Alcohol- and drug-involved driving in the United States: methodology for the 2007 National Roadside Survey. Eval Rev., 35: 319 - 353.
18. Lee, D, Schwope, D M, Milman, G, Barnes, A J, Gorelick, D A and Huestis, M A. 2012. Cannabinoid disposition in oral fluid after controlled smoked cannabis. Clin Chem., 58: 748 - 756.
19. Lestina, D C, Greene, M, Voas, R B and Wells, J. 1999. Sampling procedures and survey methodologies for the 1996 survey with comparisons to earlier National Roadside Surveys. Eval Rev., 23: 28 - 46.
20. Milman, G, Schwope, D M, Gorelick, D A and Huestis, MA. 2012. Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis. Clin Chem., 413: 765 - 770.
21. Milman, G, Schwope, D M Schwilke, E W. 2011. Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Δ(9)-tetrahydrocannabinol administration. Clin Chem., 57: 1597 - 1606.
22. Moore, C. 2012. Oral fluid for workplace drug testing: laboratory implementation. Drug Test Anal., 4: 89 - 93.
23. Moore, C, Rana, S and Coulter, C. 2007. Simultaneous identification of 2-carboxy-tetrahydrocannabinol, tetrahydrocannabinol, cannabinol and cannabidiol in oral fluid. J Chromatogr B Biomed Sci Appl., 852: 459 - 464.
24. National Center for Statistics and Analysis. National Automotive Sampling System (NASS) Crashworthiness Data System: Analytical User's Manual, Washington, DC: US Department of Transportation, National Highway Traffic Safety Administration. 2006
25. National Center for Statistics and Analysis. Traffic Safety Facts: Drug Involvement of Fatally Injured Drivers, Washington, DC: US Department of Transportation, National Highway Traffic Safety Administration. DOT HS 811 415. Available at: http://www-nrd.nhtsa.dot.gov/Pubs/811415.pdf 2010
26. Occupational Safety and Health Administration. OSHA Law & Regulations. 2013. U.S. Department of Labor: Washington, DC. Available at: https://www.osha.gov/law-regs.html. Accessed February, 2013
27. Scheidweiler, K B, Spargo, E A, Kelly, T L, Cone, E J, Barnes, A J and Huestis, M A. 2010. Pharmacokinetics of cocaine and metabolites in human oral fluid and correlation with plasma concentrations after controlled administration. Ther Drug Monit., 32: 628 - 637.
28. Schepers, R J, Oyler, J M, Joseph, R E Jr, Cone, E J, Moolchan, E T and Huestis, MA. 2003. Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin Chem., 49: 121 - 132.
29. Toennes, S W, Steinmeyer, S, Maurer, H J, Moeller, M R and Kauert, GF. 2005. Screening for drugs of abuse in oral fluid-correlation of analysis results with serum in forensic cases. J Anal Toxicol., 29: 22 - 27.
30. Tuyay, J, Coulter, C, Rodrigues, W and Moore, C. 2012. Disposition of opioids in oral fluid: importance of chromatography and mass spectral transitions in LC-MS/MS. Drug Test Anal., 4: 395 - 401.
31. Van der Linden, T, Legrand, S A, Silverans, P and Verstraete, A G. 2012. DUID: oral fluid and blood confirmation compared in Belgium. J Anal Toxicol., 36: 418 - 421.
32. Vindenes, V, Lund, H M Andresen, W. 2012. Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers. Forensic Sci Int., 219: 165 - 171.
33. Walsh, J M, Flegel, R Atkins, R. 2005. Drug and alcohol use among drivers admitted to a Level-1 trauma center. Accid Anal Prev., 37: 894 - 901.
34. Wille, S M, Raes, E Lillsunde, P. 2009. Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs. Ther Drug Monit., 31: 511 - 519.